Thomas Decker
Ravensburg University of Cooperative Education(DE)HOPE Clinic(US)MVZ Labor Ravensburg(DE)Praxis für Hämatologie und Onkologie(DE)RWTH Aachen University(DE)
Publications by Year
Research Areas
Advanced Breast Cancer Therapies, Breast Cancer Treatment Studies, Colorectal Cancer Treatments and Studies, Cancer Treatment and Pharmacology, HER2/EGFR in Cancer Research
Most-Cited Works
- → FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial(2014)1,720 cited
- → Breast cancer prognostic classification in the molecular era: the role of histological grade(2010)979 cited
- → Magnetic resonance imaging of the breast: Recommendations from the EUSOMA working group(2010)966 cited
- → Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists(2010)668 cited
- → FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer (FIRE-3): a post-hoc analysis of tumour dynamics in the final RAS wild-type subgroup of this randomised open-label phase 3 trial(2016)411 cited
- → Buparlisib plus fulvestrant in postmenopausal women with hormone-receptor-positive, HER2-negative, advanced breast cancer progressing on or after mTOR inhibition (BELLE-3): a randomised, double-blind, placebo-controlled, phase 3 trial